Genetic Influence on Incidence of Acute Lung Injury
遗传对急性肺损伤发生率的影响
基本信息
- 批准号:7796690
- 负责人:
- 金额:$ 35.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Lung InjuryAdult Respiratory Distress SyndromeAfrican AmericanAnimalsAntioxidantsArchivesAreaBiological AssayBlood specimenCandidate Disease GeneCellsClinicalCodeCohort StudiesCritical IllnessDataDevelopmentDrug Metabolic DetoxicationElementsEnrollmentEnzymesErythrocytesFundingFutureGenesGeneticGenetic PolymorphismGenetic ScreeningGenetic VariationGenotypeGlutathione S-TransferaseGoalsHaplotypesIn VitroIncidenceKnowledgeLinkLung diseasesModelingMolecularNational Heart, Lung, and Blood InstituteOxidantsOxidative StressPathogenesisPathway interactionsPatientsPatternPhiladelphiaPlayPopulationPopulations at RiskPositioning AttributePrincipal InvestigatorProductionPromoter RegionsProtein IsoformsReactive Oxygen SpeciesRelative (related person)Research InfrastructureResistanceResourcesRiskRisk FactorsRoleSamplingSingle Nucleotide PolymorphismSourceSpecific qualifier valueStructureSubgroupSystemTestingTraumaVariantbasecatalasecaucasian Americancohortexperiencehealthy volunteerlung injurymetropolitanoxidant stressoxidative damageperoxiredoxinpreventprogramspromoterprospective
项目摘要
The goal of this project is to identify functional gene polymorphisms and/or haplotypes in specific antioxidant genes that are associated with an increased risk of Acute Lung Injury (ALl) and its more severe form, the Acute Respiratory Distress Syndrome (ARDS), among patients with major trauma. We hypothesize that genetic variations that alter the function of enzymes that regulate oxidant production and detoxification will increase the risk of ALI/ARDS in critically ill patients who have experienced major trauma. The current proposal builds on our established cohort study infrastructure that was developed and refined by our group as part of a previous NHLBI SCOR in ALI/ARDS. Two key anti-oxidant genes (catalase and GSTpi) will be examined based on experimental data suggesting they play an important role in lung disease and preliminary analyses suggesting an association of single nucleotide polymorphisms (SNPs) with increased ALI/ARDS risk. 1-cys peroxiredoxin (PRDX6) will be studied because of the mounting evidence suggesting the importance of this enzyme in protecting against oxidative damage and the central position of this enzyme in this PO1 proposal. In Aim 1, the gene and haplotype structure of the catalase, GSTpi, and PRDX6 genes will be determined in 90 healthy volunteers. Haplotype
structures generated will be used to test associations with ALI/ARDS risk in Aim 2 and guide the functional analyses of Aim 3. In Aim 2, the association of candidate SNPs in catalase, GSTpi, and PRDX6 with risk of ALI/ARDS will be determined in patients who have experienced major trauma using an estimated 635 subjects in our major trauma cohort study (273 already enrolled and 362 to be enrolled). Association of single SNP's, haplotypes and genotype interactions will be examined. In Aim 3, the functional significance of observed SNPs in the candidate genes will be determined using cell and animal-based models. This proposal will add to the understanding of the genetic basis of ALI/ARDS pathogenesis and increase knowledge about how these genes interact with other relevant clinical risk factors. The findings of this study could potentially be used to suggest genetic screening strategies aimed at preventing ALI/ARDS in at-risk populations. Finally, this cohort study will serve as a valuable resource to test the interaction of regulators of oxidant stress with other pathophysiological pathways in ALI/ARDS in future studies.
该项目的目的是在特定的抗氧化剂基因中鉴定功能性基因多态性和/或单倍型,这些基因与急性肺损伤(ALL)及其更严重的形式(急性呼吸遇险综合征(ARDS))相关,在重大伤害患者中。我们假设改变调节氧化剂产生和排毒的酶功能的遗传变异将增加患有严重创伤的重症患者的ALI/ARDS的风险。当前的提案建立在我们既定的队列研究基础设施基础上,该基础设施是由我们小组开发和完善的,作为先前NHLBI SCOR的ALI/ARDS的一部分。将根据实验数据检查两个关键的抗氧化剂基因(过氧化氢酶和GSTPI),这表明它们在肺部疾病中起着重要作用,并进行初步分析,这表明单核苷酸多态性(SNP)与ALI/ARDS风险增加的相关性。将研究1-CYS过氧蛋白(PRDX6),因为有越来越多的证据表明该酶在预防氧化损伤和该酶的中心位置在PO1提案中的中心位置。在AIM 1中,将在90名健康志愿者中确定过氧化氢酶,GSTPI和PRDX6基因的基因和单倍型结构。单倍型
生成的结构将用于测试目标2中ALI/ARDS风险的关联,并指导目标3的功能分析。在AIM 2中,在Catalase,GSTPI和PRDX6中候选SNP的关联与ALI/ARD的风险相关,将在患者中使用估计的635个受试者在我们的重大创伤研究中经历过大量创伤的患者(273)(273)。将检查单个SNP,单倍型和基因型相互作用的关联。在AIM 3中,使用细胞和基于动物的模型确定候选基因中观察到的SNP的功能意义。该建议将增加对ALI/ARDS发病机理的遗传基础的理解,并增加有关这些基因如何与其他相关临床危险因素相互作用的知识。这项研究的发现可能有可能用于提出旨在防止高危人群中ALD的遗传筛查策略。最后,这项队列研究将作为在未来的研究中测试ALI/ARDS中氧化应激的调节剂与其他病理生理途径的相互作用的宝贵资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Mark Albelda其他文献
Steven Mark Albelda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Mark Albelda', 18)}}的其他基金
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
项目2 - 临床前研究:克服肿瘤异质性
- 批准号:
10241978 - 财政年份:2018
- 资助金额:
$ 35.67万 - 项目类别:
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
项目2 - 临床前研究:克服肿瘤异质性
- 批准号:
10006192 - 财政年份:2018
- 资助金额:
$ 35.67万 - 项目类别:
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
将嵌合抗原 (CAR) T 细胞疗法扩展到胸部癌症
- 批准号:
10006051 - 财政年份:2018
- 资助金额:
$ 35.67万 - 项目类别:
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
将嵌合抗原 (CAR) T 细胞疗法扩展到胸部癌症
- 批准号:
10241975 - 财政年份:2018
- 资助金额:
$ 35.67万 - 项目类别:
The role of TIM3 and CEACAM1 in anti-tumor function of human effector T cells
TIM3和CEACAM1在人效应T细胞抗肿瘤功能中的作用
- 批准号:
10215429 - 财政年份:2017
- 资助金额:
$ 35.67万 - 项目类别:
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
使用靶向肿瘤基质的基因工程 T 细胞治疗肺癌
- 批准号:
8578578 - 财政年份:2013
- 资助金额:
$ 35.67万 - 项目类别:
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
使用靶向肿瘤基质的基因工程 T 细胞治疗肺癌
- 批准号:
9101792 - 财政年份:2013
- 资助金额:
$ 35.67万 - 项目类别:
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
使用靶向肿瘤基质的基因工程 T 细胞治疗肺癌
- 批准号:
8739623 - 财政年份:2013
- 资助金额:
$ 35.67万 - 项目类别:
相似国自然基金
肺撞击伤的生物力学机理及其并发ARDS的病理机制研究
- 批准号:39370670
- 批准年份:1993
- 资助金额:5.3 万元
- 项目类别:面上项目
刺激性气体致成人呼吸窘迫综合征的机理及诊断防治研究
- 批准号:39270582
- 批准年份:1992
- 资助金额:4.0 万元
- 项目类别:面上项目
相似海外基金
Mitochondrial Determinants of Cognitive Outcomes in ARDS and Sepsis
ARDS 和脓毒症认知结果的线粒体决定因素
- 批准号:
9883826 - 财政年份:2017
- 资助金额:
$ 35.67万 - 项目类别:
Statistical and Computational Methods for Large-Scale Sequencing Studies
大规模测序研究的统计和计算方法
- 批准号:
9377731 - 财政年份:2016
- 资助金额:
$ 35.67万 - 项目类别:
Statistical and Computational Methods for Large-Scale Sequencing Studies
大规模测序研究的统计和计算方法
- 批准号:
9013897 - 财政年份:2015
- 资助金额:
$ 35.67万 - 项目类别:
Genetic variation and biomarkers in children with acute lung injury
急性肺损伤儿童的遗传变异和生物标志物
- 批准号:
8058814 - 财政年份:2009
- 资助金额:
$ 35.67万 - 项目类别: